1 吴秋英,吴小霞.Gsk-3β在卵巢浆液性肿瘤中的表达及意义.齐齐哈尔医学院学报,2015,10:1425-1426. 2 Yeganeh PN,Richardson C,Bahrani-Mostafavi Z,et al.Dysregulation of AKT3 along with a small panel of mRNAs stratifies high-grade serous ovarian cancer from both normal epithelia and benign tumor tissues.Genes Cancer,2017,8:784-798. 3 Nguyen L,Cardenas-Goicoechea SJ,Gordon P,et al.Biomarkers for early detection of ovarian cancer.Womens Health,2013,9:171-187. 4 Gatcliffe T A,Monk B J,Planutis K,et al.Wnt signaling in ovarian tumorigenesis.Int.J.Gynecol.Cancer,2010,18:954-962. 5 Dai YQ,Guan Q,Liu Q,et al.Expression of β-catenin and c-myc of the Wnt signaling pathway in ovarian serous adenocarcinoma and the roles in prognosis.Chinese Journal of Clinical Experimental Pathology,2014,7:81026-81048. 6 Chen S,Sun KX,Feng MX,et al.Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.Drug Des Devel Ther,2016,10:1225-1232. 7 Georgievska B,Sandin J,Doherty J,et al.AZD1080,a novel GSK3 inhibitor,rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.J Neurochem,2013,125:446-456. 8 Li T,Lai Q,Wang S,et al.MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer.J Exp Clin Cancer Res,2016,35:1-11. 9 Liu Y,Duan LJ,Wan SF,et al.Evaluation of Wnt signaling pathway activity and tumor malignant biological behavior in ovarian cancer.Journal of Hainan Medical University,2015,21:724-727. 10 李康,旦增.Wnt/β-catenin信号与胃癌防治研究进展.南方医科大学学报,2014,12:1852-1856. 11 Enzo MV,Rastrelli M,Rossi CR,et al.The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target.Mol Cell Ther,2015,3:1-13. 12 张世蘋,张旭.Wnt信号通路在肿瘤调控方面的研究进展.中国药理学通报,2017,33:14-18. 13 Ning YX,Luo X,Xu M,et al.Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc.Oncotarget,2017,8:74836-74845.